Acadian Asset Management’s Immune Design Corp. IMDZ Stock Holding History

Acadian Asset Management’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-44,566	Closed	-$58K	–	2134
2018 Q4	$58K	Buy	+44,566	New	+$77.5K	﹤0.01%	1395
2017 Q4	–	Sell	-4,032	Closed	-$42K	–	1777
2017 Q3	$42K	Buy	+4,032	New	+$39.7K	﹤0.01%	1129
2017 Q2	–	Sell	-4,673	Closed	-$32K	–	1768
2017 Q1	$32K	Buy	+4,673	New	+$27K	﹤0.01%	1310

Other funds holding IMDZ

Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

SAM

Sandell Asset Management New York $179M AUM 65.55% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Acadian Asset Management's IMDZ Position: Q1 2019 in Review

Acadian Asset Management sold out of Immune Design Corp. (IMDZ) in Q1 2019, closing a stake of 44,566 shares — an estimated $58K sold.

Acadian Asset Management first reported a position in IMDZ in Q1 2017 and held it in 3 quarters. The position peaked at $58K in Q4 2018. 68 funds tracked by Wall St. Rank hold IMDZ as of Q1 2019.

Acadian Asset Management reported no remaining Immune Design Corp. position as of Q1 2019 after selling out during the quarter.
Acadian Asset Management sold 44,566 Immune Design Corp. shares in Q1 2019, an estimated $58K.
Acadian Asset Management first reported a position in Immune Design Corp. in Q1 2017 and held it in 3 quarters.
Acadian Asset Management's Immune Design Corp. position peaked at $58K in Q4 2018.
68 funds tracked by Wall St. Rank held Immune Design Corp. as of Q1 2019.

Based on Acadian Asset Management's 13F filing for Q1 2019, filed 9 May 2019.